drugset / Trial / NCT05544214
Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
This study is an open-label, randomized, single dose, crossover study to evaluate the pharmacokinetics, safety and tolerability of CKD-388 in healthy subjects
Timeline
- Start
- 2022-10-21
- Primary completion
- 2022-11-14
- Completion
- 2022-11-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CKD-371 | Unknown | — | — |